High-performance liquid chromatography-diode array and electrospray-mass spectrometry analysis of non-allowed substances in cosmetic products for preventing hair loss and other hormone-dependent skin diseases

被引:43
作者
De Orsi, Daniela [1 ]
Pellegrini, Manuela [1 ]
Pichini, Simona [1 ]
Mattioli, Donatella [1 ]
Marchei, Emilia [1 ]
Gagliardi, Luigi [1 ]
机构
[1] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy
关键词
HPLC-ESI-MS; HPLC-UV-DAD; Cosmetics; Minoxidil; Hormones;
D O I
10.1016/j.jpba.2008.06.008
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple high-performance liquid chromatography (HPLC) method with ultraviolet diode array (UV-DAD) and electrospray ionisation mass spectrometry (ESI-MS) detection has been developed for the determination of minoxidil, progesterone, estrone, spironolactone, canrenone, hydrocortisone and triamcinolone acetonide in cosmetic products. The presence of these substances in commercial cosmetic samples is prohibited. The compounds were separated by reversed phase chromatography with water (0.1% trifluoroacetic acid) and acetonitrile gradient elution and detected by UV-DAD at 230, 254 and 280 nm and by ESI-MS positive ionisation mode. Benzoic acid was used as internal standard. Linearity was studied with UV-DAD detection from 1.50 to 1000 mu g/ml or mu g/g range, depending on the different compounds and type of cosmetic preparation and with ESI-MS in the 50-1000 ng/ml or ng/g range. Good determination coefficients (r(2) >= 0.99) were found in both UV and ESI-MS. At three concentrations spanning the linear dynamic ranges of both UV-DAD and ESI-MS assay, mean recoveries were always higher than 90% for the different analytes. This method was successfully applied to the analysis of substances under investigations illegally added in cosmetic cream and lotions, sold on internet web sites to prevent hair loss and other hormone-dependent skin diseases, like acne and hirsutism. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:641 / 648
页数:8
相关论文
共 27 条
[1]  
[Anonymous], 2001, Guidance for industry, bioanalytical method validation
[2]   Acne: more than skin deep [J].
Ayer, J. ;
Burrows, N. .
POSTGRADUATE MEDICAL JOURNAL, 2006, 82 (970) :500-506
[3]  
Dinh QQ, 2007, CLIN INTERV AGING, V2, P189
[4]   Simultaneous determination of spironolactone and its active metabolite canrenone in human plasma by HPLC-APCI-MS [J].
Dong, HJ ;
Xu, FG ;
Zhang, ZJ ;
Tian, Y ;
Chen, Y .
JOURNAL OF MASS SPECTROMETRY, 2006, 41 (04) :477-486
[5]   Development of a tandem thin-layer chromatography-high-performance liquid chromatography method for the identification and determination of corticosteroids in cosmetic products [J].
Gagliardi, L ;
De Orsi, D ;
Del Giudice, MR ;
Gatta, F ;
Porrà, R ;
Chimenti, P ;
Tonelli, D .
ANALYTICA CHIMICA ACTA, 2002, 457 (02) :187-198
[6]   Treatment of female pattern hair loss with a combination of spironolactone and minoxidil [J].
Hoedemaker, Carlijn ;
van Egmond, Sylvia ;
Sinclair, Rodney .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2007, 48 (01) :43-45
[7]  
*ICH TECHN COORD, 1996, ICH TOPIC Q 2 B VALI
[8]   Development and validation of a high-performance liquid chromatography-mass spectrometry assay for methylxanthines and taurine in dietary supplements [J].
Marchei, E ;
Pellegrini, M ;
Pacifici, R ;
Palmi, I ;
Pichini, S .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 37 (03) :499-507
[9]   Treatments for androgenetic alopecia and alopecia areata - Current options and future prospects [J].
Meidan, VM ;
Touitou, E .
DRUGS, 2001, 61 (01) :53-69
[10]   Hirsutism [J].
Mofid, A. ;
Alinaghi, S. A. Seyyed ;
Zandieh, S. ;
Yazdani, T. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (03) :433-443